Quick Answer
IDEAYA Biosciences, Inc. reported R&D Expense of $314.70 million for fiscal year 2025.
IDEAYA Biosciences, Inc. R&D Expense — Annual History
| Fiscal Year | R&D Expense | YoY Change |
|---|---|---|
| 2025 | $314.70M | +6.8% |
| 2024 | $294.67M | +127.5% |
| 2023 | $129.51M | +44.6% |
| 2022 | $89.54M | +54.0% |
| 2021 | $58.16M | +46.5% |
| 2020 | $39.70M | +15.7% |
| 2019 | $34.32M | +8.1% |
| 2018 | $31.75M | +156.4% |
| 2017 | $12.38M | — |
Quarterly R&D Expense
| Quarter Ending | R&D Expense | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $82.99M | +45.2% | +11.8% |
| June 30, 2025 | $74.23M | +36.1% | +4.7% |
| March 31, 2025 | $70.89M | +65.6% | +24.0% |
| September 30, 2024 | $57.15M | +69.6% | +4.8% |
| June 30, 2024 | $54.53M | +86.9% | +27.4% |
| March 31, 2024 | $42.80M | +53.6% | +27.0% |
| September 30, 2023 | $33.70M | +50.6% | +15.5% |
| June 30, 2023 | $29.18M | +28.0% | +4.7% |
- IDEAYA Biosciences, Inc. showed an increase of +6.8% in R&D Expense compared to the prior fiscal year.
- Over the 2017–2025 period, IDEAYA Biosciences, Inc.’s r&d expense has grown by 2441.2% (from $12.38 million to $314.70 million).
- The most recent figure is from IDEAYA Biosciences, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 17, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: